2LS.F SILOAM INTL HOS. RP 125

Healthcare Health Care Providers & Services Frankfurt Exchange
0.0740 EUR
Close of Nov 11, 2026
0.0740 0.1390
Market cap
EUR 961M
P/E
-
P/B
2.05x
ROE
11.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 2LS.F undervalued?

Graham number

The Graham number of SILOAM INTL HOS. RP 125 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

SILOAM INTL HOS. RP 125 fundamental analysis

No fundamental analysis for SILOAM INTL HOS. RP 125 yet.

SILOAM INTL HOS. RP 125 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About SILOAM INTL HOS. RP 125

PT Siloam International Hospitals Tbk operates hospitals and clinics in Indonesia. The company offers general, pre-marital, and lite checkups; male and female screenings; heart, kidney, and cancer screenings; visa application and preemployment screenings; and vaccine and genomic testing services. It also provides diagnostic services, including laboratory and radiology checks; home services; COVID-19 tests; radiation therapy; and teleconsultation services. In addition, it off…

Full company profile